Dualitas Therapeutics, Inc. of SOUTH SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2025-11-18. The offering totals $66.6M, of which $32.6M was reported sold. Industry: Biotechnology.
| Name | Role | Location |
|---|---|---|
| Thomas Hudson | Director | South San Francisco, CA |
| Alicia Levey | Director | South San Francisco, CA |
| Mark McDade | Director | South San Francisco, CA |
| Richard Murray | Director | South San Francisco, CA |
| Michael Ross | Director | South San Francisco, CA |
| Nikola Trbovic | Director | Waltham, MA |
| Neil Weir | Director | South San Francisco, CA |
| Forbes Huang | Executive Officer | South San Francisco, CA |
| Greg Lazar | Executive Officer | South San Francisco, CA |
| Richard Murray | Executive Officer | South San Francisco, CA |